Your browser doesn't support javascript.
loading
Severe Drug-Induced Interstitial Lung Disease After Administration of Osimertinib as Adjuvant Treatment for Resected EGFR-Mutated NSCLC: A Case Report.
Mitsuya, Sho; Arai, Masahiro; Kanaoka, Kiyoe; Funamoto, Tomoya; Tsuji, Hiroyuki; Tsuruoka, Kenjiro; Matsunaga, Ninso; Nakamura, Takahiko; Tamura, Yosuke; Imanishi, Masafumi; Ikeda, Soichiro; Imagawa, Akihisa; Fujisaka, Yasuhito.
Afiliación
  • Mitsuya S; Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
  • Arai M; Internal Medicine (I), Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Kanaoka K; Medical Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Funamoto T; Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
  • Tsuji H; Internal Medicine (I), Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Tsuruoka K; Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
  • Matsunaga N; Internal Medicine (I), Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Nakamura T; Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
  • Tamura Y; Internal Medicine (I), Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Imanishi M; Medical Oncology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Ikeda S; Clinical Research Center, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
  • Imagawa A; Respiratory Medicine and Thoracic Oncology, Osaka Medical and Pharmaceutical University Hospital, Osaka, Japan.
  • Fujisaka Y; Internal Medicine (I), Osaka Medical and Pharmaceutical University, Osaka, Japan.
JTO Clin Res Rep ; 5(2): 100631, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38322711

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JTO Clin Res Rep Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JTO Clin Res Rep Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos